FLNC Gene Splice Mutations Cause Dilated Cardiomyopathy

Summary A genetic etiology has been identified in 30% to 40% of dilated cardiomyopathy (DCM) patients, yet only 50% of these cases are associated with a known causative gene variant. Thus, in order to understand the pathophysiology of DCM, it is necessary to identify and characterize additional gene...

Full description

Saved in:
Bibliographic Details
Published in:JACC. Basic to translational science Vol. 1; no. 5; pp. 344 - 359
Main Authors: Begay, Rene L., BS, Tharp, Charles A., MD, Martin, August, Graw, Sharon L., PhD, Sinagra, Gianfranco, MD, Miani, Daniela, MD, Sweet, Mary E., BA, Slavov, Dobromir B., PhD, Stafford, Neil, MD, Zeller, Molly J, Alnefaie, Rasha, Rowland, Teisha J., PhD, Brun, Francesca, MD, Jones, Kenneth L., PhD, Gowan, Katherine, Mestroni, Luisa, MD, Garrity, Deborah M., PhD, Taylor, Matthew R.G., MD, PhD
Format: Journal Article
Language:English
Published: United States Elsevier Inc 01-08-2016
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary A genetic etiology has been identified in 30% to 40% of dilated cardiomyopathy (DCM) patients, yet only 50% of these cases are associated with a known causative gene variant. Thus, in order to understand the pathophysiology of DCM, it is necessary to identify and characterize additional genes. In this study, whole exome sequencing in combination with segregation analysis was used to identify mutations in a novel gene, filamin C ( FLNC ), resulting in a cardiac-restricted DCM pathology. Here we provide functional data via zebrafish studies and protein analysis to support a model implicating FLNC haploinsufficiency as a mechanism of DCM.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2452-302X
2452-302X
DOI:10.1016/j.jacbts.2016.05.004